| Schedule For Net Loss Per Share |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Basic |
|
|
|
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders |
|
$ |
(1.8 |
) |
|
$ |
(2.0 |
) |
|
$ |
(5.5 |
) |
|
$ |
(5.6 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
12,252,342 |
|
|
|
11,085,657 |
|
|
|
11,902,010 |
|
|
|
10,633,664 |
|
Basic net loss per share |
|
$ |
(0.15 |
) |
|
$ |
(0.18 |
) |
|
$ |
(0.47 |
) |
|
$ |
(0.53 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders, basic |
|
$ |
(1.8 |
) |
|
$ |
(2.0 |
) |
|
$ |
(5.5 |
) |
|
$ |
(5.6 |
) |
Effect of dilutive securities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Net loss, diluted |
|
$ |
(1.8 |
) |
|
$ |
(2.0 |
) |
|
$ |
(5.5 |
) |
|
$ |
(5.6 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - basic |
|
|
12,252,342 |
|
|
|
11,085,657 |
|
|
|
11,902,010 |
|
|
|
10,633,664 |
|
Potential common share issuances: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
12,252,342 |
|
|
|
11,085,657 |
|
|
|
11,902,010 |
|
|
|
10,633,664 |
|
Diluted net loss per share |
|
$ |
(0.15 |
) |
|
$ |
(0.18 |
) |
|
$ |
(0.47 |
) |
|
$ |
(0.53 |
) |
|